Page last updated: 2024-08-22

thioflavin t and a-Synucleinopathies

thioflavin t has been researched along with a-Synucleinopathies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bertoni, M; Bezard, E; Claverol, S; Daniel, J; De Giorgi, F; Doudnikoff, E; Dutheil, N; Faggiani, E; Grélard, A; Habenstein, B; Ichas, F; Laferrière, F; Lends, A; Loquet, A; Morvan, E; Qin, C; Yu, X; Zinghirino, F1
Fukuhara, T; Hatano, T; Hattori, N; Imai, Y; Nukina, N; Okuzumi, A; Ueno, S1
Anantharam, V; Hepker, M; Huang, X; Jin, H; Kanthasamy, A; Kanthasamy, AG; Kondru, N; Lewis, M; Manne, S1

Other Studies

3 other study(ies) available for thioflavin t and a-Synucleinopathies

ArticleYear
Novel self-replicating α-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons.
    Science advances, 2020, Volume: 6, Issue:40

    Topics: alpha-Synuclein; Amyloid; Animals; Benzothiazoles; Mice; Neurons; Synucleinopathies

2020
α-Synuclein Seeding Assay Using RT-QuIC.
    Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2322

    Topics: alpha-Synuclein; Benzothiazoles; Biological Assay; Brain; Humans; Kinetics; Prion Proteins; Protein Aggregates; Synucleinopathies

2021
Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2019, Volume: 14, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Animals; Benzothiazoles; Biomarkers; Brain Chemistry; Case-Control Studies; Computer Systems; Fluorescent Dyes; Fluorometry; High-Throughput Screening Assays; Humans; Lewy Body Disease; Mice; Microglia; Middle Aged; Neuroglia; Parkinsonian Disorders; Protein Aggregates; Recombinant Proteins; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Synucleinopathies

2019